Squarepoint
ETRA

Squarepoint’s Electra Therapeutics, Inc. Common stock ETRA Stock Holding History

Squarepoint’s Portfolio ETRA Stock Details ETRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$492K Buy
+43,768
New +$539K ﹤0.01% 3394

Other funds holding ETRA

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Monashee Investment Management
Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Squarepoint's ETRA Position: Q3 2026 in Review

Squarepoint opened a new position in Electra Therapeutics, Inc. Common stock (ETRA) in Q3 2026: 43,768 shares worth $492K. The stake represents ﹤0.01% of the portfolio and ranks #3394 among its holdings.

7 funds tracked by Wall St. Rank hold ETRA as of Q3 2026.

  • Squarepoint held 43,768 shares of Electra Therapeutics, Inc. Common stock worth $492K as of Q3 2026.
  • Electra Therapeutics, Inc. Common stock was a new Squarepoint position in Q3 2026.
  • Electra Therapeutics, Inc. Common stock made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3394 holding.
  • 7 funds tracked by Wall St. Rank held Electra Therapeutics, Inc. Common stock as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.